Literature DB >> 24067897

Patterns and predictors of naturally occurring change in depressive symptoms over a 30-month period in multiple sclerosis.

Ipek Ensari1, Robert W Motl, Edward McAuley, Sean P Mullen, Anthony Feinstein.   

Abstract

BACKGROUND: Depressive symptoms are common in multiple sclerosis (MS), yet there is little information about the pattern and predictors of changes in depressive symptoms over time.
OBJECTIVE: We examined changes in depressive symptoms over a 30-month period and the demographic, clinical and behavioral predictors of such changes in relapsing-remitting MS (RRMS).
METHODS: 269 persons with RRMS completed the Hospital Anxiety and Depression Scale (HADS) and a demographic/clinical scale, Godin Leisure-Time Exercise Questionnaire (GLTEQ) and Patient Determined Disease Steps (PDDS) scale every 6 months over a 30-month period. Data were analyzed using latent class growth modeling (LCGM).
RESULTS: LCGM identified a two-class model for changes in HADS depression scores over time. Class 1 involved lower initial status (i.e. fewer depressive symptoms) and linear decreases in depressive symptoms over time (i.e. improving HADS scores), whereas Class 2 involved higher initial status (i.e. more depressive symptoms) and linear increases in depressive symptoms over time (i.e. worsening HADS scores). LCGM further indicated that being older (OR = 2.46; p < .05), married (OR = 2.62; p < .05), employed (OR = 4.29; p < .005) and physically active (OR = 2.71; p < .05) predicted a greater likelihood of belonging to C1 than C2.
CONCLUSIONS: Depressive symptoms change over time in persons with RRMS, and the pattern of change can be predicted by modifiable and non-modifiable factors.

Entities:  

Keywords:  Depression; factors; longitudinal study; multiple sclerosis; physical activity; predictive model; questionnaire; relapsing–remitting multiple sclerosis

Mesh:

Year:  2013        PMID: 24067897     DOI: 10.1177/1352458513504251

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  5 in total

Review 1.  Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).

Authors:  Rachel E Klaren; Robert W Motl; Jeffrey A Woods; Stephen D Miller
Journal:  J Neuroimmunol       Date:  2014-06-24       Impact factor: 3.478

2.  Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis.

Authors:  Keryn L Taylor; Emily J Hadgkiss; George A Jelinek; Tracey J Weiland; Naresh G Pereira; Claudia H Marck; Dania M van der Meer
Journal:  BMC Psychiatry       Date:  2014-12-03       Impact factor: 3.630

3.  A telemedicine meditation intervention for people with multiple sclerosis and their caregivers: study protocol for a randomized controlled trial.

Authors:  Cesare Cavalera; Francesco Pagnini; Marco Rovaris; Laura Mendozzi; Luigi Pugnetti; Massimo Garegnani; Enrico Molinari
Journal:  Trials       Date:  2016-01-04       Impact factor: 2.279

4.  Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study.

Authors:  Ingo Kleiter; Michael Lang; Judith Jeske; Christiane Norenberg; Barbara Stollfuß; Markus Schürks
Journal:  BMC Neurol       Date:  2017-09-06       Impact factor: 2.474

5.  Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires.

Authors:  Anja Fischer; Marcus Fischer; Robert A Nicholls; Stephanie Lau; Jana Poettgen; Kostas Patas; Christoph Heesen; Stefan M Gold
Journal:  Brain Behav       Date:  2015-07-14       Impact factor: 2.708

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.